Crossmark

Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment

Crossref DOI link: https://doi.org/10.1007/s42000-018-0083-8

Published Online: 2018-11-22

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Polyzos, Stergios A. https://orcid.org/0000-0001-9232-4042
Kountouras, Jannis

Anastasilakis, Athanasios D.

Makras, Polyzois

Hawa, Gerhard

Sonnleitner, Linda

Missbichler, Albert

Doulberis, Michael

Katsinelos, Panagiotis

Terpos, Evangelos
License Information

Text and Data Mining valid from 2018-11-22
More Information

Article History

Received: 26 September 2018

Accepted: 14 November 2018

First Online: 22 November 2018

Compliance with ethical standards

: All participants provided informed consent at baseline. The study protocol was in accordance with the Declaration of Helsinki and was approved by the ethics committee of the Medical School, Aristotle University of Thessaloniki.

: G. Hawa, L. Sonnleitner, and A. Missbichler are employees of FIANOSTICS GmbH, Wiener Neustadt, Austria. All other authors have no potential conflict of interests.